Publicacions (282) Publicacions de RAFAEL TABARES SEISDEDOS

2024

  1. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

    The Lancet, Vol. 403, Núm. 10440, pp. 2204-2256

  2. Efficiency assessment of follow-up methodology of patients with knee replacement to predict post-surgical functionality: a protocol for randomised control PROKnee trial

    BMJ open, Vol. 14, Núm. 5, pp. e077942

  3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet, Vol. 403, Núm. 10440, pp. 2162-2203

  4. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet, Vol. 403, Núm. 10440, pp. 2133-2161

  5. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet Neurology, Vol. 23, Núm. 4, pp. 344-381

2023

  1. A cross-sectional analysis identified co-authorship networks and scientific collaboration on reporting guidelines for health research

    Journal of Clinical Epidemiology, Vol. 157, pp. 22-34

  2. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

    The Lancet Global Health, Vol. 11, Núm. 3, pp. e385-e413

  3. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet, Vol. 402, Núm. 10397, pp. 203-234

  4. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

    eClinicalMedicine, Vol. 64

  5. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019

    The Lancet Public Health, Vol. 8, Núm. 9, pp. e701-e716

  6. Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127

  7. Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase

    Drugs - Real World Outcomes, Vol. 10, Núm. 2, pp. 263-270

  8. The Burden of Type 1 and Type 2 Diabetes Among Adolescents and Young Adults in 24 Western European Countries, 1990–2019: Results From the Global Burden of Disease Study 2019

    International Journal of Public Health, Vol. 68

  9. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019

    The Lancet, Vol. 402, Núm. 10398, pp. 313-335

2022

  1. A Cofactor-Based Mechanism for the Origin of the Genetic Code

    Origins of Life and Evolution of Biospheres, Vol. 52, Núm. 1-3, pp. 149-163

  2. A GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain

    Scientific Reports, Vol. 12, Núm. 1

  3. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019

    The Lancet Public Health, Vol. 7, Núm. 8, pp. e657-e669

  4. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

    The Lancet Global Health, Vol. 10, Núm. 12, pp. e1715-e1743

  5. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 367-383

  6. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019

    JAMA Oncology, Vol. 8, Núm. 3, pp. 420-444